Stockscreener 앱 받기
0.00
100.00%
-0.0322
시간 외 거래:
.03
0.03
+
전일 마감가:
$0.0322
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$3.80M
수익:
$1.33M
순이익/손실:
$-138.49M
주가수익비율:
0.00
EPS:
-1.2
순현금흐름:
$-126.22M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$2.94
Gritstone Bio Inc Stock (GRTS) Company Profile
명칭
Gritstone Bio Inc
전화
(510) 871-6100
주소
5959 HORTON STREET, SUITE 300, EMERYVILLE, CA
GRTS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GRTS
Gritstone Bio Inc
|
0.00 | 3.80M | 1.33M | -138.49M | -126.22M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
488.34 | 125.40B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.16 | 78.51B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
580.43 | 35.27B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
238.74 | 30.91B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
245.71 | 26.37B | 3.32B | -860.46M | -1.04B | -8.32 |
Gritstone Bio Inc Stock (GRTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-03-31 | 개시 | Evercore ISI | Outperform |
| 2023-03-28 | 개시 | B. Riley Securities | Buy |
| 2022-10-31 | 개시 | Piper Sandler | Overweight |
| 2022-08-22 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-12-15 | 재개 | Goldman | Neutral |
| 2021-10-15 | 재개 | BTIG Research | Buy |
| 2021-01-20 | 다운그레이드 | Robert W. Baird | Outperform → Underperform |
| 2019-07-26 | 개시 | Robert W. Baird | Outperform |
| 2019-03-15 | 개시 | Raymond James | Outperform |
| 2019-03-07 | 개시 | H.C. Wainwright | Buy |
| 2018-10-23 | 개시 | BTIG Research | Buy |
| 2018-10-23 | 개시 | Goldman | Neutral |
모두보기
Gritstone Bio Inc 주식(GRTS)의 최신 뉴스
Investors who lost money on Gritstone bio, Inc.(GRTS) should contact Levi & Korsinsky about pending Class ActionGRTS - ACCESS Newswire
Lost Money on Gritstone bio, Inc.(GRTS)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Levi & Korsinsky Reminds Gritstone bio, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 6, 2024GRTS - ACCESS Newswire
GRTS DEADLINE ALERT: Bernstein Liebhard LLP Reminds Gritstone bio, Inc. Investors of Upcoming Deadline - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 6, 2024 in Gritstone LawsuitGRTS - ACCESS Newswire
GRTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Gritstone bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Delisting of Securities of Adamas One Corp.; Hempacco Co., Inc.; Iris Acquisition Corp; Aura FAT Projects Acquisition Corp.; Newbury Street Acquisition Corporation; Arogo Capital Acquisition Corp.; Compass Digital Acquisition Corp.; Gritstone bio, Inc.; Notabl - The Manila Times
10 Companies Purged From Nasdaq: What Happened to These Suspended Stocks? - StockTitan
Shareholders of Gritstone bio, Inc. Should Contact Levi & Korsinsky Before August 6, 2024 to Discuss Your RightsGRTS - ACCESS Newswire
Gritstone bio files monthly operating report amid Chapter 11 By Investing.com - Investing.com South Africa
Gritstone bio Files for Chapter 11 Bankruptcy - TipRanks
Gritstone bio files monthly operating report amid Chapter 11 - Investing.com
FINAL GRTS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Gritstone bio, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
GRTS SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Gritstone bio, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
GRTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Gritstone bio, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Investigation announced for Long-Term Investors in Gritstone bio, Inc. (NASDAQ: GRTS) over potential Wrongdoing - openPR
Cancer Vaccines Therapeutics Market Size Report 2032 | - openPR
GRITSTONE BIO, INC. (NASDAQ: GRTS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Gritstone bio, Inc. Investors of Upcoming Deadline - ACCESS Newswire
Gritstone (GRTS) Plummets 58% in a Week: Here's Why - MSN
Gritstone bio completes asset sale amid bankruptcy - Investing.com India
Gritstone bio completes asset sale amid bankruptcy By Investing.com - Investing.com Australia
Seattle Project Corp agreed to acquire Substantially all of the assets of Gritstone bio, Inc. from Gritstone bio, Inc. (OTCPK:GRTS.Q) for $21.2 million. - Marketscreener.com
Seattle Project Corp completed the acquisition of Substantially all of the assets of Gritstone bio, Inc. from Gritstone bio, Inc. (OTCPK:GRTS.Q). - Marketscreener.com
Leader of failed biotech urges others to hire colleagues - The Business Journals
Gritstone Bio, Inc. Announces Resignation of Executives - Marketscreener.com
Gritstone Bio, Inc. Announces CEO Changes - Marketscreener.com
Gritstone bio Completes Asset Sale Amid Bankruptcy - TipRanks
GRTS Investors Have the Opportunity to Lead Gritstone bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GuruFocus.com
Gritstone bio CFO sells $180 in common stock - Investing.com India
Gritstone bio CFO sells $180 in common stock By Investing.com - Investing.com Australia
Gritstone bio assets auctioned for $21.25 million By Investing.com - Investing.com South Africa
Gritstone bio assets auctioned for $21.25 million - Investing.com
Gritstone Bio sets sale of assets through Bankruptcy Court - The Business Journals
Gritstone Bio Files for Bankruptcy and Auctions Assets - TipRanks
B. Riley Securities Downgrades Gritstone bio (GRTS) - MSN
Gritstone bio reports October financials amid Chapter 11 - Investing.com India
Gritstone bio reports October financials amid Chapter 11 By Investing.com - Investing.com South Africa
Gritstone bio (GRTSQ) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - MSN
Bidding Procedure Approved for Gritstone bio, Inc. - Marketscreener.com
Final DIP Financing Approved for Gritstone bio, Inc. - Marketscreener.com
Gritstone bio : Bankruptcy Form 8 K - Marketscreener.com
Gritstone Bio Inc (GRTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.14%
2.83%
자본화:
|
볼륨(24시간):